Switch to:
More From Other Websites
Global scientific collaborators to explore latest pathology and oncology advancements at Tucson... Mar 03 2015
Roche's Avastin Gets Positive Opinion for Cervical Cancer - Analyst Blog Mar 02 2015
Will Exelixis (EXEL) Miss Estimates this Earnings Season? - Analyst Blog Feb 23 2015
A 'Great Entry Point' for AbbVie; Pfizer a 'Value Creation Machine' Feb 20 2015
Regeneron's Eylea Tops Diabetic Macular Edema Study - Analyst Blog Feb 19 2015
Update: Regeneron: Too Much Excitement About Eylea News? Feb 19 2015
FDA Grants Genentech’s Cobimetinib Priority Review for Use in Combination with Zelboraf... Feb 19 2015
The Sham Of Drug Testing For Benefits: Walker, Scott And Political Pandering Feb 17 2015
ROCHE HOLDING LTD /FI Financials Feb 12 2015
Pfenex Inc. In Development Pact For Macular Degeneration Drug Feb 10 2015
Roche's Lucentis Gets FDA Nod for Diabetic Retinopathy - Analyst Blog Feb 09 2015
Glaxo Submits Another Revolade Application in the EU - Analyst Blog Feb 09 2015
Tetraphase Fights Drug-Resistant Bugs As M&A Heats Up Feb 09 2015
Roche acquires Signature Diagnostics to advance translational research for next generation... Feb 09 2015
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Treatment of Diabetic Retinopathy... Feb 06 2015
Roche Holding AG (RHHBY): New Analyst Report from Zacks Equity Research - Zacks Equity Research... Feb 06 2015
Roche Reports Positive Data on Leukemia Drug Gazyva - Analyst Blog Feb 05 2015
Exelixis Data Release Upcoming; Options Activity Spiking Feb 05 2015
Amgen Reveals Positive Results on Biosimilar Candidate - Analyst Blog Feb 04 2015
Genentech’s Phase III Study of Gazyva® Showed Significant Benefit in Refractory Indolent... Feb 04 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Steve.dunfield@google
ReplySteve.dunfield@google - 11 months ago
Adjust for split?


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK